Uniform Mesh Structure Innovation: Tetra-Gel

Gellycle Co., Ltd.

Control Gel, Transform Medical Care

As a pioneering bio-venture, we leverage the groundbreaking Tetra-Gel technology developed by Professor Sakai at the University of Tokyo for medical and industrial applications. Our mission is to harness this highly biocompatible, cutting-edge gel technology to innovate across multiple medical products, introducing a novel approach we call Gel Medicine. Through strategic partnerships, we aim to forge new markets and drive innovation.

In today's world, countless diseases remain without a cure. Our core mission is to address these unmet medical needs, utilizing our world-leading gel control technology to enhance the quality of life for patients globally.

BUSINESS DETAILS

Company Name
Gellycle Co., Ltd.
Date of Establishment
8/1/2018
Head Office Location
Sakae bldg. 2F, 3-38-1 Hongo, Bunkyo-ku, Tokyo 113-0033
Location of Factories
Sakae bldg. 2F, 3-38-1 Hongo, Bunkyo-ku, Tokyo 113-0033
Representative
Kousuke Masui
Company Site (Japanese)
https://gellycle.com/home
Company Site (English)
https://gellycle.com/home-en
Major Business Partners
Cosmo Bio, Kaigen Pharma, Medico's Hirata, Nof, Xiamen Sinopeg Biotech
Industry
Medical device manufacturer
Achievements
Berkeley SkyDeck 2023, University Venture Award 2023, University Venture Award Special Prize, ICC Kyoto 2021 Real Tech Catapult Championship